Eiko Imamiya

835 total citations
16 papers, 691 citations indexed

About

Eiko Imamiya is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Eiko Imamiya has authored 16 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 4 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Eiko Imamiya's work include Synthesis and biological activity (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (3 papers). Eiko Imamiya is often cited by papers focused on Synthesis and biological activity (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (3 papers). Eiko Imamiya collaborates with scholars based in Japan. Eiko Imamiya's co-authors include Yasuhisa Kohara, Keiji Kubo, Takehiko Naka, Yoshiyuki Inada, Takeo Wada, Y. Kawamatsu, Katsutoshi Mizuno, Takashi Sohda, Yasuo Sugiyama and Takeshi Fujita and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Chemical and Pharmaceutical Bulletin.

In The Last Decade

Eiko Imamiya

16 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiko Imamiya Japan 10 396 305 59 56 51 16 691
Steven A. Boyd United States 18 320 0.8× 322 1.1× 71 1.2× 63 1.1× 40 0.8× 34 739
C. John Blankley United States 17 510 1.3× 419 1.4× 114 1.9× 90 1.6× 123 2.4× 33 1.0k
Yoshiyasu Furukawa Japan 12 366 0.9× 374 1.2× 80 1.4× 33 0.6× 38 0.7× 35 707
Alexander Chucholowski Germany 14 670 1.7× 537 1.8× 89 1.5× 95 1.7× 50 1.0× 24 956
Catherine Sekerke United States 16 222 0.6× 278 0.9× 26 0.4× 70 1.3× 102 2.0× 19 645
Candido Gude United States 12 487 1.2× 196 0.6× 23 0.4× 67 1.2× 50 1.0× 24 670
Peter Herold Switzerland 13 572 1.4× 474 1.6× 150 2.5× 86 1.5× 24 0.5× 17 905
Aldo Balsamo Italy 18 358 0.9× 258 0.8× 46 0.8× 69 1.2× 37 0.7× 56 747
Leonard L. Winneroski United States 14 399 1.0× 492 1.6× 24 0.4× 83 1.5× 34 0.7× 22 901
Richard Göschke Switzerland 10 281 0.7× 339 1.1× 229 3.9× 48 0.9× 86 1.7× 12 628

Countries citing papers authored by Eiko Imamiya

Since Specialization
Citations

This map shows the geographic impact of Eiko Imamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiko Imamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiko Imamiya more than expected).

Fields of papers citing papers by Eiko Imamiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiko Imamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiko Imamiya. The network helps show where Eiko Imamiya may publish in the future.

Co-authorship network of co-authors of Eiko Imamiya

This figure shows the co-authorship network connecting the top 25 collaborators of Eiko Imamiya. A scholar is included among the top collaborators of Eiko Imamiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiko Imamiya. Eiko Imamiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fukumoto, Shoji, et al.. (2002). Novel, Non-acylguanidine-type Na+/H+ Exchanger Inhibitors:  Synthesis and Pharmacology of 5-Tetrahydroquinolinylidene Aminoguanidine Derivatives. Journal of Medicinal Chemistry. 45(14). 3009–3021. 38 indexed citations
2.
Kohara, Yasuhisa, Keiji Kubo, Eiko Imamiya, & Takehiko Naka. (2000). A facile synthesis of 3‐Substituted 5‐Oxo‐1,2,4‐thiadiazoles from amidoximes. Journal of Heterocyclic Chemistry. 37(6). 1419–1423. 9 indexed citations
3.
Kohara, Yasuhisa, Keiji Kubo, Eiko Imamiya, et al.. (1996). Synthesis and Angiotensin II Receptor Antagonistic Activities of Benzimidazole Derivatives Bearing Acidic Heterocycles as Novel Tetrazole Bioisosteres. Journal of Medicinal Chemistry. 39(26). 5228–5235. 240 indexed citations
4.
Kohara, Yasuhisa, Eiko Imamiya, Keiji Kubo, et al.. (1995). A new class of angiotensin II receptor antagonists with a novel acidic bioisostere. Bioorganic & Medicinal Chemistry Letters. 5(17). 1903–1908. 41 indexed citations
5.
Kubo, Keiji, Yasuhisa Kohara, Eiko Imamiya, et al.. (1993). Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids. Journal of Medicinal Chemistry. 36(15). 2182–2195. 117 indexed citations
6.
UKAWA, K., Eiko Imamiya, Hiroaki Yamamoto, et al.. (1989). Synthesis and antitumor activity of new alkylphospholipids containing modifications of the phosphocholine moiety.. Chemical and Pharmaceutical Bulletin. 37(5). 1249–1255. 17 indexed citations
7.
UKAWA, K., Eiko Imamiya, Hiroaki Yamamoto, et al.. (1989). Synthesis and antitumor activity of new amphiphilic alkylglycerolipids substituted with a polar head group, 2-(2-trimethylammonioethoxy)ethyl or a congeneric oligo(ethyleneoxy)ethyl group.. Chemical and Pharmaceutical Bulletin. 37(12). 3277–3285. 12 indexed citations
8.
Akimoto, Hiroshi, Eiko Imamiya, Takenori Hitaka, Hiroaki Nomura, & Susumu Nishimura. (1988). Synthesis of queuine, the base of naturally occurring hypermodified nucleoside (queuosine), and its analogues. Journal of the Chemical Society Perkin Transactions 1. 1637–1637. 30 indexed citations
9.
Sohda, Takashi, Katsutoshi Mizuno, Eiko Imamiya, et al.. (1982). Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.. Chemical and Pharmaceutical Bulletin. 30(10). 3601–3616. 19 indexed citations
10.
Sohda, Takashi, Katsutoshi Mizuno, Eiko Imamiya, et al.. (1982). Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.. Chemical and Pharmaceutical Bulletin. 30(10). 3580–3600. 137 indexed citations
11.
12.
Kawamatsu, Y., et al.. (1980). Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.. PubMed. 30(3). 454–9. 9 indexed citations
13.
Imamiya, Eiko, et al.. (1980). ChemInform Abstract: STUDIES ON ANTIHYPERLIPIDEMIC AGENTS. II. SYNTHESIS AND BIOLOGICAL ACTIVITIES S OF 2‐CHLORO‐3‐ARYLPROPIONIC ACIDS. Chemischer Informationsdienst. 11(31). 585–9. 7 indexed citations
14.
Imamiya, Eiko, et al.. (1979). Chemistry of salicylic acid and anthranilic acid. I. Reduction of methyl salicylate, methyl anthranilate and their derivatives with sodium borohydride.. Chemical and Pharmaceutical Bulletin. 27(2). 522–527. 6 indexed citations
15.
Imamiya, Eiko, et al.. (1979). Chemistry of salicylic acid and anthranilic acid. III. Hypoglycemic screening tests for salicylic and anthranilic acid derivatives.. Chemical and Pharmaceutical Bulletin. 27(6). 1468–1472. 3 indexed citations
16.
Oka, Yoshikazu, Eiko Imamiya, & Hiroshi Hirano. (1967). Studies on Vitamin B<SUB>1</SUB> and Related Compounds.CVII.Synthesis of Hydroxyethylthiamine Homologs. Chemical and Pharmaceutical Bulletin. 15(4). 448–453. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven A. Boyd Breakdown of academic impact, for papers by C. John Blankley Breakdown of academic impact, for papers by Yoshiyasu Furukawa Breakdown of academic impact, for papers by Alexander Chucholowski Breakdown of academic impact, for papers by Catherine Sekerke Breakdown of academic impact, for papers by Candido Gude Breakdown of academic impact, for papers by Peter Herold Breakdown of academic impact, for papers by Aldo Balsamo Breakdown of academic impact, for papers by Leonard L. Winneroski Breakdown of academic impact, for papers by Richard Göschke
Rankless by CCL
2026